Avapritinib in advanced PDGFRA D842V-mutant gastrointestinal stromal tumour (NAVIGATOR): a multicentre, open-label, phase 1 trial

MC Heinrich; RL Jones; M von Mehren; P Schoffski; C Serrano; YK Kang; PA Cassier; O Mir; Ferry Eskens; WD Tap; P Rutkowski; SP Chawla; J Trent; M Tugnait; EK Evans; T Lauz; T Zhou; M Roche; BB Wolf; S Bauer; S (Shanti) George

doi:10.1016/S1470-2045(20)30269-2

Avapritinib in advanced PDGFRA D842V-mutant gastrointestinal stromal tumour (NAVIGATOR): a multicentre, open-label, phase 1 trial

MC Heinrich, RL Jones, M von Mehren, P Schoffski, C Serrano, YK Kang, PA Cassier, O Mir, Ferry Eskens, WD Tap, P Rutkowski, SP Chawla, J Trent, M Tugnait, EK Evans, T Lauz, T Zhou, M Roche, BB Wolf, S BauerS (Shanti) George

Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

220 Citations (Scopus)

Original language	English
Pages (from-to)	935-946
Number of pages	12
Journal	Lancet Oncology
Volume	21
Issue number	7
DOIs	https://doi.org/10.1016/S1470-2045(20)30269-2
Publication status	Published - 2020

Research programs

EMC OR-01

Access to Document

10.1016/S1470-2045(20)30269-2

Cite this

Heinrich, MC., Jones, RL., von Mehren, M., Schoffski, P., Serrano, C., Kang, YK., Cassier, PA., Mir, O., Eskens, F., Tap, WD., Rutkowski, P., Chawla, SP., Trent, J., Tugnait, M., Evans, EK., Lauz, T., Zhou, T., Roche, M., Wolf, BB., ... George, S. (2020). Avapritinib in advanced PDGFRA D842V-mutant gastrointestinal stromal tumour (NAVIGATOR): a multicentre, open-label, phase 1 trial. Lancet Oncology, 21(7), 935-946. https://doi.org/10.1016/S1470-2045(20)30269-2

@article{cd160b9824414aaeb7587af4caf18149,

title = "Avapritinib in advanced PDGFRA D842V-mutant gastrointestinal stromal tumour (NAVIGATOR): a multicentre, open-label, phase 1 trial",

author = "MC Heinrich and RL Jones and {von Mehren}, M and P Schoffski and C Serrano and YK Kang and PA Cassier and O Mir and Ferry Eskens and WD Tap and P Rutkowski and SP Chawla and J Trent and M Tugnait and EK Evans and T Lauz and T Zhou and M Roche and BB Wolf and S Bauer and George, {S (Shanti)}",

year = "2020",

doi = "10.1016/S1470-2045(20)30269-2",

language = "English",

volume = "21",

pages = "935--946",

journal = "Lancet Oncology",

issn = "1470-2045",

publisher = "Elsevier Ltd.",

number = "7",

}

Heinrich, MC, Jones, RL, von Mehren, M, Schoffski, P, Serrano, C, Kang, YK, Cassier, PA, Mir, O, Eskens, F, Tap, WD, Rutkowski, P, Chawla, SP, Trent, J, Tugnait, M, Evans, EK, Lauz, T, Zhou, T, Roche, M, Wolf, BB, Bauer, S & George, S 2020, 'Avapritinib in advanced PDGFRA D842V-mutant gastrointestinal stromal tumour (NAVIGATOR): a multicentre, open-label, phase 1 trial', Lancet Oncology, vol. 21, no. 7, pp. 935-946. https://doi.org/10.1016/S1470-2045(20)30269-2

TY - JOUR

T1 - Avapritinib in advanced PDGFRA D842V-mutant gastrointestinal stromal tumour (NAVIGATOR): a multicentre, open-label, phase 1 trial

AU - Heinrich, MC

AU - Jones, RL

AU - von Mehren, M

AU - Schoffski, P

AU - Serrano, C

AU - Kang, YK

AU - Cassier, PA

AU - Mir, O

AU - Eskens, Ferry

AU - Tap, WD

AU - Rutkowski, P

AU - Chawla, SP

AU - Trent, J

AU - Tugnait, M

AU - Evans, EK

AU - Lauz, T

AU - Zhou, T

AU - Roche, M

AU - Wolf, BB

AU - Bauer, S

AU - George, S (Shanti)

PY - 2020

Y1 - 2020

U2 - 10.1016/S1470-2045(20)30269-2

DO - 10.1016/S1470-2045(20)30269-2

M3 - Article

C2 - 32615108

SN - 1470-2045

VL - 21

SP - 935

EP - 946

JO - Lancet Oncology

JF - Lancet Oncology

IS - 7

ER -